Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.

Matteo BramuzzoFabiola GiudiciSerena ArrigoPaolo LionettiGiovanna ZuinClaudio RomanoFrancesco GrazianoSimona FaraciPatrizia AlvisiSara SignaLuca ScaralloStefano MartelossiGrazia Di Leo

Published in: Inflammatory bowel diseases (2023)

Thalidomide is an effective and tolerated treatment in children with VEOIBD. Discontinuation due to lack of efficacy is more frequent, but AEs are less common than in children with pIBD.

Keyphrases

early onset
late onset
young adults
combination therapy